Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kukolj, G.
35  Ergebnisse:
Personensuche X
?
1

P1129 EFFECT OF HCV GENOTYPE-1 SUBTYPE ON RESPONSE TO FALDA..:

Jacobson, I.M. ; Jensen, D.M. ; Dieterich, D....
Journal of Hepatology.  60 (2014)  1 - p. S457 , 2014
Link: https://doi.org/10.1016/..
 
?
2

P1134 DURATION OF UNDETECTABLE HCVRNA IN PATIENTS TREATED W..:

Dufour, J.-F. ; Zeuzem, S. ; Buti, M....
Journal of Hepatology.  60 (2014)  1 - p. S459-S460 , 2014
Link: https://doi.org/10.1016/..
 
?
3

P1227 FALDAPREVIR EFFICACY IN HCV GENOTYPE-1-INFECTED PATIE..:

Berger, K. ; Sarrazin, C. ; Jacobson, I.M....
Journal of Hepatology.  60 (2014)  1 - p. S497 , 2014
Link: https://doi.org/10.1016/..
 
?
4

O12 RESTORATION OF HCV-SPECIFIC CD8+ T-CELL RESPONSES WITH ..:

Martin, B. ; Hennecke, N. ; Blum, H.E....
Journal of Hepatology.  60 (2014)  1 - p. S6 , 2014
Link: https://doi.org/10.1016/..
 
?
5

P1226 NS3 Q80K DID NOT IMPACT EFFICACY OR TREATMENT-EMERGEN..:

Berger, K. ; Sarrazin, C. ; Ferenci, P....
Journal of Hepatology.  60 (2014)  1 - p. S497 , 2014
Link: https://doi.org/10.1016/..
 
?
6

P1121 EARLY STOPPING RULES FOR FALDAPREVIR PLUS PEGYLATED I..:

Ferenci, P. ; Dieterich, D. ; Zeuzem, S....
Journal of Hepatology.  60 (2014)  1 - p. S452-S453 , 2014
Link: https://doi.org/10.1016/..
 
?
7

1209 IMPACT OF EARLY RESPONSE DEFINITIONS ON DURATION AND O..:

Sulkowski, M. ; Asselah, T. ; Ferenci, P....
Journal of Hepatology.  56 (2012)  - p. S479-S480 , 2012
Link: https://doi.org/10.1016/..
 
?
8

101 SVR4 AND SVR12 WITH AN INTERFERON-FREE REGIMEN OF BI201..:

Zeuzem, S. ; Soriano, V. ; Asselah, T....
Journal of Hepatology.  56 (2012)  - p. S45 , 2012
Link: https://doi.org/10.1016/..
 
?
9

822 PRECLINICAL CHARACTERIZATION OF THE HEPATITIS C VIRUS N..:

Beaulieu, P.L. ; Anderson, P.C. ; Brochu, C....
Journal of Hepatology.  56 (2012)  - p. S321 , 2012
Link: https://doi.org/10.1016/..
 
?
10

1185 CHARACTERIZATION OF HCV NS3 VARIANTS THAT EMERGED DURI..:

Kukolj, G. ; Bethell, R. ; Cartier, M....
Journal of Hepatology.  56 (2012)  - p. S469 , 2012
Link: https://doi.org/10.1016/..
 
?
11

1215 PRECLINICAL CHARACTERIZATION OF THE HEPATITIS C VIRUS ..:

Kukolj, G. ; Anderson, P.C. ; Boes, M....
Journal of Hepatology.  54 (2011)  - p. S480 , 2011
Link: https://doi.org/10.1016/..
 
?
12

777 PRECLINICAL CHARACTERIZATION OF NON-COVALENT HCV NS3/4A..:

White, P.W. ; Llinas-Brunet, M. ; Amad, M....
Journal of Hepatology.  52 (2010)  - p. S302 , 2010
Link: https://doi.org/10.1016/..
 
?
13

758 CHARACTERIZATION OF RESISTANT MUTANTS SELECTED IN VITRO..:

Kukolj, G. ; Bousquet, C. ; Dansereau, N....
Journal of Hepatology.  52 (2010)  - p. S295 , 2010
Link: https://doi.org/10.1016/..
 
?
14

954 BI 201335, A POTENT HCV NS3 PROTEASE INHIBITOR, IN TREA..:

Kukolj, G. ; Benhamou, Y. ; Manns, M.P....
Journal of Hepatology.  50 (2009)  - p. S347 , 2009
Link: https://doi.org/10.1016/..
 
?
15

The bacteriophage D108 Ner repressor binds a conformational..:

Kukolj, G. ; DuBow, M. S.
Molecular and General Genetics MGG.  263 (2000)  4 - p. 592-600 , 2000
Link: https://doi.org/10.1007/..
 
1-15